论文信息 - Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease - 字舞流文

Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease

M. Calleja | F. Argüelles-Arias | M. G. Guerra Veloz | L. Castro Laria | Á. Vilches Arenas | R. Perea Amarillo | A. Caunedo Álvarez | B. Maldonado Pérez | A. Benítez Roldán | V. Merino Bohórquez | Á. Caunedo Álvarez | V. Merino Bohórquez | Á. Vilches Arenas